Lee Baumgarten1, Ali A Dabaja2. 1. Henry Ford Health System, 2799 W. Grand Blvd, Detroit, MI, 48202, USA. 2. Henry Ford Health System, 2799 W. Grand Blvd, Detroit, MI, 48202, USA. adabaja2@hfhs.org.
Abstract
PURPOSE OF REVIEW: Our aim is to review the steps of diagnosis and management of gynecomastia with a special focus on treatment of gynecomastia associated with androgen deprivation therapy for prostate cancer. RECENT FINDINGS: Recent studies investigating tamoxifen and radiation therapy for both therapy and prophylaxis of bicalutamide-induced gynecomastia are reviewed. Gynecomastia is a common clinical problem, affecting between one and two thirds of middle-aged men. Diagnosis is typically made by history and physical exam. Common causes include chronic medical conditions and medications; however, unexplained gynecomastia should prompt laboratory work-up, followed by appropriate imaging studies to evaluate for hormone producing cancers. For patients taking bicalutamide for treatment of prostate cancer, tamoxifen or radiation therapy for gynecomastia are excellent options.
PURPOSE OF REVIEW: Our aim is to review the steps of diagnosis and management of gynecomastia with a special focus on treatment of gynecomastia associated with androgen deprivation therapy for prostate cancer. RECENT FINDINGS: Recent studies investigating tamoxifen and radiation therapy for both therapy and prophylaxis of bicalutamide-induced gynecomastia are reviewed. Gynecomastia is a common clinical problem, affecting between one and two thirds of middle-aged men. Diagnosis is typically made by history and physical exam. Common causes include chronic medical conditions and medications; however, unexplained gynecomastia should prompt laboratory work-up, followed by appropriate imaging studies to evaluate for hormone producing cancers. For patients taking bicalutamide for treatment of prostate cancer, tamoxifen or radiation therapy for gynecomastia are excellent options.
Authors: F Boccardo; A Rubagotti; M Battaglia; P Di Tonno; F P Selvaggi; G Conti; G Comeri; A Bertaccini; G Martorana; P Galassi; F Zattoni; A Macchiarella; A Siragusa; G Muscas; F Durand; D Potenzoni; A Manganelli; V Ferraris; F Montefiore Journal: J Clin Oncol Date: 2005-02-01 Impact factor: 44.544
Authors: G F Evans; T Anthony; R H Turnage; T D Schumpert; K R Levy; R H Amirkhan; T J Campbell; J Lopez; A H Appelbaum Journal: Am J Surg Date: 2001-02 Impact factor: 2.565
Authors: Paul L Nguyen; Shabbir M H Alibhai; Shehzad Basaria; Anthony V D'Amico; Philip W Kantoff; Nancy L Keating; David F Penson; Derek J Rosario; Bertrand Tombal; Matthew R Smith Journal: Eur Urol Date: 2014-08-02 Impact factor: 20.096